Free tool
Drug Trial Radar
Last checked: Nov 20, 2026Latest source record: Nov 20, 2026 (registry update on this page)ClinicalTrials.gov last updated: Nov 20, 2026Methods & limitations
Filters
Filters are saved in the page address, so a filtered view can be bookmarked or shared.
Matching drug trials
60
Recruiting, any sponsor type, condition "insomnia"
By trial status
The same filters, counted in each status. Pick one to switch.
- Completed419
60 trials
Showing 1 to 25, recently updated first.
- Sleep Quality - Comparing the Effect of Ondansetron or Dexamethasone Given as Routine Prophylaxis Intraoperatively to Prevent Post Operative Nausea and Vomiting (SCORPION)Pivotal-lookingRecruiting
Telethon Kids InstituteAcademic, hospital or other
NCT07777276 · 500 participants (planned) · Start Aug 3, 2026 · Primary completion Aug 17, 2029
Drug: Dexamethasone (IV); Ondansetron iv · For: Postoperative Sleep Quality; Postoperative Behaviour; Postoperative Recovery in Children and 3 more
Sites: Perth, Australia; São Paulo, Brazil · 3 sites in all
National Yang Ming Chiao Tung UniversityAcademic, hospital or other
NCT07929311 · 100 participants (planned) · Start Oct 24, 2026 · Primary completion Aug 31, 2027
Drug: running activities · For: Running-related Injuries
Sites: Taipei, Taiwan
- The Role of mGluR5 in CBT-IRecruiting
Stony Brook UniversityAcademic, hospital or other
NCT07076342 · 42 participants (planned) · Start Aug 1, 2025 · Primary completion Mar 31, 2030
Drug: PET Scan with [11C]ABP688 · For: Major Depressive Disorder (MDD)
Sites: Stony Brook, New York
- A Trial to See if Daridorexant Can Help Adults and Elderly People With Insomnia Sleep Better During the Night and Function Better During the DayPivotal-lookingRecruiting
Idorsia Pharmaceuticals Ltd.Industry
NCT07843329 · 344 participants (planned) · Start Oct 28, 2026 · Primary completion Nov 22, 2027
Drug: Daridorexant; Placebo · For: Insomia Disorder
Sites: Little Rock, Arkansas; Lemon Grove, California; Pomona, California · 9 sites in all
- The Effects of Orexin Antagonism on Fear Extinction in PTSDPivotal-lookingRecruiting
VA Office of Research and DevelopmentFederal agency
NCT06788522 · 40,120 participants (planned) · Start Jul 1, 2026 · Primary completion Mar 1, 2032
Drug: Suvorexant; Placebo · For: Insomnia; PTSD
Sites: San Francisco, California; Charleston, South Carolina
- Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia SymptomsPivotal-lookingRecruiting
Janssen Research & Development, LLCJohnson & Johnson (Janssen) (JNJ)
NCT06559306 · 752 participants (planned) · Start Jul 25, 2024 · Primary completion Dec 30, 2026
Drug: Seltorexant; Placebo and 1 more · For: Depressive Disorder, Major
Sites: Birmingham, Alabama; Chandler, Arizona; Tucson, Arizona · 205 sites in all
Salem Anaesthesia Pain ClinicAcademic, hospital or other
NCT05618002 · 250 participants (planned) · Start Jan 2, 2023 · Primary completion Jun 28, 2027
Drug: Lemborexant · For: Chronic Insomnia; Chronic Pain; Restless Leg Syndrome (RLS) and 6 more
Sites: Surrey, Canada
- Sodium Oxybate for Postoperative Sleep Disturbance After Thoracic SurgeryPivotal-lookingRecruiting
Jingsheng LouAcademic, hospital or other
NCT07794982 · 360 participants (planned) · Start Sep 1, 2026 · Primary completion Dec 2027
Drug: sodium oxybate; Placebo · For: Thoracic Surgical Procedures
Sites: Beijing, China
Broad Institute of MIT and HarvardAcademic, hospital or other
NCT07444580 · 45 participants (planned) · Start May 15, 2026 · Primary completion Aug 14, 2029
Drug: PrP-siRNA · For: Prion Disease
Sites: Boston, Massachusetts; Rochester, Minnesota; New York, New York · 5 sites in all
- Suvorexant for Treatment of AUD and PTSDRecruiting
Pharmacotherapies for Alcohol and Substance Use Disorders AllianceAcademic, hospital or other
NCT06679062 · 76 participants (planned) · Start Jul 16, 2025 · Primary completion Mar 2027
Drug: Suvorexant · For: Alcohol Use Disorder (AUD); Post Traumatic Stress Disorder (PTSD); Insomnia
Sites: Los Angeles, California; Houston, Texas
- Stellate Ganglion Block and Dexmedetomidine for Postoperative Sleep in Women Undergoing Laparoscopic Gynecologic SurgeryPivotal-lookingRecruiting
Catherin ZhangAcademic, hospital or other
NCT07860203 · 100 participants (planned) · Start Oct 2026 · Primary completion Dec 2026
Drug: DEX 0.2 μg/kg/h.; 0.9% Sodium Chloride (Placebo) · For: Uterine Fibroids (Leiomyoma); Adenomyosis of Uterus; Endometriosis and 3 more
Sites: Huai'an, China
- Study on the Management of COMISARecruiting
University Hospital, GrenobleAcademic, hospital or other
NCT07743931 · 150 participants (planned) · Start Sep 30, 2026 · Primary completion Sep 2028
Drug: Daridorexant 50 mg · For: Obstructive Sleep Apnea (OSA); Insomnia; COMISA
Sites: Grenoble, France; Marseille, France; Metz, France · 5 sites in all
- Effect of Preoperative Melatonin on Quality of Recovery After Elective Laparoscopic CholecystectomyRecruiting
Armed Forces Medical Institute BangladeshAcademic, hospital or other
NCT07553143 · 84 participants (planned) · Start May 1, 2026 · Primary completion Dec 31, 2026
Drug: Melatonin (N-acetyl-5-methoxytryptamine); Placebo · For: Laparoscopic Cholecystectomy; Postoperative Quality of Recovery; Preoperative Anxiety and 3 more
Sites: Dhaka, Bangladesh
- A Study of Suvorexant (MK-4305) for the Treatment of Insomnia Disorder in Participants With Opioid Use Disorder (MK-4305-098)Pivotal-lookingRecruiting
Merck Sharp & Dohme LLCMerck & Co. (MRK)
NCT06655883 · 300 participants (planned) · Start Oct 9, 2025 · Primary completion Jun 24, 2027
Drug: Suvorexant; Placebo · For: Insomnia
Sites: Garden Grove, California; New Haven, Connecticut; Bradenton, Florida · 13 sites in all
- A Dual Orexin Receptor Antagonist to Reduce Biomarkers of Neurodegeneration in Adults With Insomnia.Recruiting
Woolcock Institute of Medical ResearchAcademic, hospital or other
NCT06823752 · 20 participants (planned) · Start May 13, 2025 · Primary completion Dec 2027
Drug: Lemborexant 10 MG; Placebo · For: Insomnia
Sites: Macquarie Park, Australia
- A SMART Approach to Evaluating the Benefits of Common Prescription and OTC Medications for InsomniaPivotal-lookingRecruiting
University of PennsylvaniaAcademic, hospital or other
NCT07542756 · 1,200 participants (planned) · Start May 1, 2026 · Primary completion Jan 1, 2032
Drug: Diphenhydramine, 25 mg; Diphenhydramine, 50 mg and 7 more · For: Insomnia; Insomnia Disorder; Chronic Insomnia and 1 more
Sites: Philadelphia, Pennsylvania
Tanta UniversityAcademic, hospital or other
NCT07800364 · 68 participants (planned) · Start Mar 1, 2026 · Primary completion Sep 2026
Drug: Tizanidine; Placebo · For: The Effect of Preoperative Administration of Oral Tizanidine; Post Operative Pain
Sites: Tanta, Egypt
Zhujiang HospitalAcademic, hospital or other
NCT07380113 · 50 participants (planned) · Start Jun 22, 2026 · Primary completion Dec 31, 2027
Drug: Anrikefon; Nalfurafine · For: Pruritus Chronic; Kidney Diseases, Chronic; Renal Insufficiency, Chronic and 3 more
Sites: Guangzhou, China
- Efficacy and Safety of APSTZD in the Treatment of Insomnia DisorderPivotal-lookingRecruiting
Apsen Farmaceutica S.A.Industry
NCT07420816 · 222 participants (planned) · Start Aug 5, 2026 · Primary completion Dec 2027
Drug: APSTZD 1; APSTZD 2 and 4 more · For: Insomnia; Insomnia Chronic
Sites: Bragança Paulista, Brazil
Duke UniversityAcademic, hospital or other
NCT04278404 · 5,000 participants (planned) · Start Mar 5, 2020 · Primary completion Nov 2026
Drug: The POP02 study is collecting bodily fluid samples (i.e., whole blood, effluent samples) of children prescribed the following drugs of interest per standard of care: · For: Coronavirus Infection (COVID-19); Pulmonary Arterial Hypertension; Urinary Tract Infections in Children and 22 more
Sites: Phoenix, Arizona; Little Rock, Arkansas; Los Angeles, California · 52 sites in all
- Efficacy of CBT-I With Adjuvant Melatonin in Older Adults Chronic InsomniaPivotal-lookingRecruiting
The University of Hong KongAcademic, hospital or other
NCT07695246 · 183 participants (planned) · Start Aug 1, 2026 · Primary completion Aug 1, 2029
Drug: Placebo Oral Tablet · For: Insomnia; Aging; Sleep Disorders
Sites: Hong Kong, Hong Kong
Woolcock Institute of Medical ResearchAcademic, hospital or other
NCT07392177 · 15 participants (planned) · Start Aug 12, 2026 · Primary completion Mar 2027
Drug: Dexmedetomidine; Placebo · For: Insomnia
Sites: Macquarie Park, Australia
- Effect of Dexmedetomidine Combined With FNB/ACB on Sleep Quality After Knee SurgeryPivotal-lookingRecruiting
Affiliated Hospital of Nantong UniversityAcademic, hospital or other
NCT07767383 · 136 participants (planned) · Start Jan 15, 2026 · Primary completion Sep 30, 2026
Drug: ropivacaine (local infiltration); Dexmedetomidine and 1 more · For: Knee Arthroscopic Surgery
Sites: Nantong, China
Tainan Hospital, Ministry of Health and WelfareAcademic, hospital or other
NCT07735390 · 24 participants (planned) · Start Sep 13, 2024 · Primary completion Dec 31, 2029
Drug: Chaihushugan Decoction; Wen Dan Tang · For: Insomnia; Sleep Wake Disorders
Sites: Tainan, Taiwan
Mahidol UniversityAcademic, hospital or other
NCT07737665 · 90 participants (planned) · Start Apr 1, 2025 · Primary completion Apr 1, 2027
Drug: Melatonin ("Circadin"); Placebo · For: IBD (Inflammatory Bowel Disease)
Sites: Bangkok Noi, Thailand
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.